Global Information
회사소개 | 문의 | 위시리스트

세계의 바이오서저리 시장 예측(-2023년) : 피브린 및 콜라겐 실란트, 지혈제, 유착 방지막, 생물학적 메시, 연조직 부착재, 스테이플러, 골이식편 대체물

Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2023

리서치사 MarketsandMarkets
발행일 2018년 07월 상품 코드 334025
페이지 정보 영문 315 Pages
가격
US $ 4,950 ₩ 6,027,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 8,097,000 PDF by E-mail (5-user license) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,923,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 12,176,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 바이오서저리 시장 예측(-2023년) : 피브린 및 콜라겐 실란트, 지혈제, 유착 방지막, 생물학적 메시, 연조직 부착재, 스테이플러, 골이식편 대체물 Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2023
발행일 : 2018년 07월 페이지 정보 : 영문 315 Pages

세계의 바이오서저리(바이오 외과수술) 시장은 예측기간 중 6.5%의 연평균 성장률(CAGR)로 성장하여 2018년 113억 6,000만 달러에서 2023년에는 155억 8,000만 달러로 확대될 전망입니다. 고령자 인구와 그에 따른 만성 질환 증가, 수술 건수와 중증 외상 이환율 증가, 환자의 효과적인 실혈 관리 요구 고조 등의 요인은 예측기간 중 시장 성장을 촉진할 것으로 예측됩니다. 그러나 엄격한 규제 체계, 바이오서저리 제품의 효과적인 사용에 숙련된 인재가 필요한 점은 향후 수년간 시장 성장을 어느 정도 억제할 가능성이 있습니다.

세계의 바이오서저리(Biosurgery) 시장에 대해 조사 분석했으며, 시장 개요, 산업 동향, 부문별 시장 분석, 경쟁 상황, 주요 기업 등의 정보를 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 조사 결과

  • 바이오서저리 시장 : 개요
  • 아시아태평양의 바이오서저리 시장 : 종류별, 국가별
  • 바이오서저리 시장의 지역 현황
  • 바이오서저리 시장의 지역 구성
  • 바이오서저리 시장 : 선진 시장 vs. 신흥 시장

제5장 시장 개요

  • 서론
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 과제

제6장 산업 분석

  • 산업 동향
  • 규제 분석
  • 전략 벤치마킹

제7장 바이오서저리 시장 : 제품별

  • 서론
  • 골이식편 대체물
  • 연조직 부착재(패치/메시)
  • 지혈제
  • 수술용 실란트 및 접착제
  • 유착 방지막
  • 스테이플라인 보강제

제8장 바이오서저리 시장 : 용도별

  • 서론
  • 정형외과
  • 일반외과
  • 신경외과
  • 심혈관외과
  • 재건 수술
  • 부인과 수술
  • 비뇨기외과
  • 흉부외과

제9장 바이오서저리 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제10장 경쟁 상황

  • 개요
  • 시장 점유율 분석
  • 경쟁 상황과 동향

제11장 기업 개요

  • BAXTER INTERNATIONAL INC.
  • B.BRAUN MELSUNGEN AG
  • C.R. BARD, INC.
  • JOHNSON & JOHNSON
  • MEDTRONIC, PLC.
  • MAQUET HOLDING B.V. & CO. KG.(GETINGE GROUP)
  • COHERA MEDICAL INC.
  • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • COMMONWEALTH SERUM LABORATORIES(CSL)
  • HEMOSTASIS, LLC
  • SANOFI
  • PFIZER INC.
  • STRYKER CORPORATION
  • CRYOLIFE, INC.

제12장 부록

KSM 18.07.27

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

LIST OF TABLES

  • TABLE 1: STANDARD CURRENCY CONVERSION RATES
  • TABLE 2: BIOSURGERY MARKET SNAPSHOT
  • TABLE 3: MARKET DYNAMICS: IMPACT ANALYSIS
  • TABLE 4: PERCENTAGE INCREASE IN THE NUMBER OF SURGICAL PROCEDURES PERFORMED IN THE US
  • TABLE 5: MAJOR ACQUISITIONS IN THE BIOSURGERY MARKET (2015-2017)
  • TABLE 6: NUMBER OF PRODUCT LAUNCHES BY KEY PLAYERS (2015-2018)
  • TABLE 7: INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES
  • TABLE 8: STRINGENCY OF REGULATIONS FOR BIOSURGERY PRODUCTS, BY COUNTRY
  • TABLE 9: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 10: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 11: BIOSURGERY MARKET FOR BONE-GRAFT SUBSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 12: MAJOR PRODUCTS IN THE DBM MARKET
  • TABLE 13: DEMINERALIZED BONE MATRIX MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 14: MAJOR PRODUCTS IN THE SYNTHETIC BONE GRAFTS MARKET
  • TABLE 15: SYNTHETIC BONE GRAFTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 16: MAJOR PRODUCTS IN THE BONE MORPHOGENETIC PROTEINS MARKET
  • TABLE 17: BONE MORPHOGENETIC PROTEINS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 18: MAJOR PRODUCTS IN THE OTHER BONE-GRAFT SUBSTITUTES MARKET
  • TABLE 19: OTHER BONE-GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 20: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 21: BIOSURGERY MARKET FOR SOFT-TISSUE ATTACHMENTS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 22: MAJOR PRODUCTS IN THE SYNTHETIC MESHES MARKET
  • TABLE 23: SYNTHETIC MESHES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 24: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 25: BIOLOGICAL MESHES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 26: ALLOGRAFTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: XENOGRAFTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 28: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 29: BIOSURGERY MARKET FOR HEMOSTATIC AGENTS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 30: MAJOR PRODUCTS IN THE THROMBIN-BASED HEMOSTATIC AGENTS MARKET
  • TABLE 31: THROMBIN-BASED HEMOSTATIC AGENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 32: MAJOR PRODUCTS IN THE OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS MARKET
  • TABLE 33: OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 34: MAJOR PRODUCTS IN THE COMBINATION HEMOSTATIC AGENTS
  • TABLE 35: COMBINATION HEMOSTATS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 36: BIOSURGERY MARKET FOR SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 37: BIOSURGERY MARKET FOR SURGICAL SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 38: BIOSURGERY MARKET FOR NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 39: BIOSURGERY MARKET FOR NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 40: MAJOR PRODUCTS IN THE FIBRIN SEALANTS MARKET
  • TABLE 41: FIBRIN SEALANTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 42: MAJOR PRODUCTS IN THE COLLAGEN BASED-SEALANTS MARKET
  • TABLE 43: COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 44: MAJOR PRODUCTS IN THE GELATIN BASED-SEALANTS MARKET
  • TABLE 45: GELATIN-BASED SEALANTS MARKET , BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 46: MAJOR PRODUCTS IN THE ALBUMIN BASED-SEALANTS MARKET
  • TABLE 47: ALBUMIN-BASED SEALANTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 48: OTHER NATURAL/BIOLOGICAL SEALANTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 49: NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 50: HUMAN BLOOD-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 51: ANIMAL-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 52: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 53: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 54: MAJOR PRODUCTS IN THE PEG HYDROGEL-BASED SEALANTS AND ADHESIVES MARKET
  • TABLE 55: PEG HYDROGEL-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 56: MAJOR PRODUCTS IN THE CYANOACRYLATE-BASED SEALANTS AND ADHESIVES MARKET
  • TABLE 57: CYANOACRYLATE-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 58: MAJOR URETHANE-BASED SEALANTS AND ADHESIVES IN THE MARKET
  • TABLE 59: URETHANE-BASED SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 60: OTHER SYNTHETIC AND SEMI-SYNTHETIC SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 61: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 62: BIOSURGERY MARKET FOR ADHESION BARRIERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 63: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 64: SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 65: MAJOR PRODUCTS IN THE HYALURONIC ACID-BASED ADHESION BARRIERS MARKET
  • TABLE 66: HYALURONIC ACID-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 67: MAJOR PRODUCTS IN THE REGENERATED CELLULOSE-BASED ADHESION BARRIERS MARKET
  • TABLE 68: REGENERATED CELLULOSE-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 69: MAJOR PRODUCTS IN THE PEG-BASED ADHESION BARRIERS MARKET
  • TABLE 70: PEG-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 71: MAJOR PRODUCTS IN THE OTHER SYNTHETIC ADHESION BARRIERS MARKET
  • TABLE 72: OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 73: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 74: NATURAL ADHESION BARRIERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 75: MAJOR PRODUCTS IN THE COLLAGEN AND PROTEIN ADHESION BARRIERS MARKET
  • TABLE 76: COLLAGEN AND PROTEIN ADHESION BARRIERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 77: MAJOR PRODUCTS IN THE FIBRIN-BASED ADHESION BARRIERS MARKET
  • TABLE 78: FIBRIN-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 79: MAJOR PRODUCTS IN THE STAPLE-LINE REINFORCEMENT AGENTS MARKET
  • TABLE 80: BIOSURGERY MARKET FOR STAPLE-LINE REINFORCEMENT AGENTS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 81: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 82: ORTHOPEDIC SURGERY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 83: GENERAL SURGERY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 84: NEUROLOGICAL SURGERY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 85: CARDIOVASCULAR SURGERY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 86: RECONSTRUCTIVE SURGERY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 87: COUNTRIES WITH THE HIGHEST C-SECTION RATE (2015)
  • TABLE 88: GYNECOLOGICAL SURGERY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 89: UROLOGICAL SURGERY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 90: THORACIC SURGERY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 91: BIOSURGERY MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 92: NORTH AMERICA: BIOSURGERY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 93: NORTH AMERICA: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 94: NORTH AMERICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 95: NORTH AMERICA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 96: NORTH AMERICA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 97: NORTH AMERICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 98: NORTH AMERICA: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 99: NORTH AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 100: NORTH AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 101: NORTH AMERICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 102: NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 103: NORTH AMERICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 104: NORTH AMERICA: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 105: US: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET
  • TABLE 106: US: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 107: US: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 108: US: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 109: US: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 110: US: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 111: US: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 112: US: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 113: US: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 114: US: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 115: US: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 116: US: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 117: US: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 118: CANADA: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET
  • TABLE 119: CANADA: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 120: CANADA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 121: CANADA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 122: CANADA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 123: CANADA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 124: CANADA: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 125: CANADA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 126: CANADA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 127: CANADA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 128: CANADA: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 129: CANADA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 130: CANADA: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 131: EUROPE: BIOSURGERY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 132: EUROPE: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 133: EUROPE: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 134: EUROPE: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 135: EUROPE: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 136: EUROPE: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 137: EUROPE: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 138: EUROPE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 139: EUROPE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 140: EUROPE: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 141: EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 142: EUROPE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 143: EUROPE: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 144: GERMANY: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET
  • TABLE 145: GERMANY: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 146: GERMANY: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 147: GERMANY: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 148: GERMANY: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 149: GERMANY: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 150: GERMANY: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 151: GERMANY: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 152: GERMANY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 153: GERMANY: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 154: GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 155: GERMANY: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 156: GERMANY: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 157: UK: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET
  • TABLE 158: UK: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 159: UK: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 160: UK: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 161: UK: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 162: UK: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 163: UK: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 164: UK: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 165: UK: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 166: UK: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 167: UK: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 168: UK: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 169: UK: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 170: FRANCE: KEY MACROINDICATORS FOR THE BOSURGERY MARKET
  • TABLE 171: FRANCE: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 172: FRANCE: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 173: FRANCE: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 174: FRANCE: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 175: FRANCE: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 176: FRANCE: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 177: FRANCE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 178: FRANCE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 179: FRANCE: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 180: FRANCE: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 181: FRANCE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 182: FRANCE: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 183: ITALY: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET
  • TABLE 184: ITALY: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 185: ITALY: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 186: ITALY: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 187: ITALY: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 188: ITALY: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 189: ITALY: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 190: ITALY: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 191: ITALY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 192: ITALY: SOFT-TISSUE ATTACHMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 193: ITALY: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 194: ITALY: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 195: ITALY: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 196: SPAIN: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET
  • TABLE 197: SPAIN: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 198: SPAIN: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 199: SPAIN: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 200: SPAIN: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 201: SPAIN: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 202: SPAIN: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 203: SPAIN: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 204: SPAIN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 205: SPAIN: SOFT-TISSUE ATTACHMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 206: SPAIN: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 207: SPAIN: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 208: SPAIN: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 209: ROE: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 210: ROE: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 211: ROE: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 212: ROE: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 213: ROE: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 214: ROE: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 215: ROE: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 216: ROE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 217: ROE: SOFT-TISSUE ATTACHMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 218: ROE: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 219: ROE: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 220: ROE: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 221: APAC: BIOSURGERY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 222: APAC: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 223: APAC: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 224: APAC: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 225: APAC: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 226: APAC: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 227: APAC: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 228: APAC: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 229: APAC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 230: APAC: SOFT-TISSUE ATTACHMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 231: APAC: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 232: APAC: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 233: APAC: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 234: JAPAN: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET
  • TABLE 235: JAPAN: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 236: JAPAN: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 237: JAPAN: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 238: JAPAN: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 239: JAPAN: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 240: JAPAN: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 241: JAPAN: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 242: JAPAN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 243: JAPAN: SOFT-TISSUE ATTACHMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 244: JAPAN: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 245: JAPAN: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 246: JAPAN: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 247: CHINA: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET
  • TABLE 248: CHINA: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 249: CHINA: SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 250: CHINA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 251: CHINA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 252: CHINA: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 253: CHINA: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 254: CHINA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 255: CHINA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 256: CHINA: SOFT-TISSUE ATTACHMENT MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 257: CHINA: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 258: CHINA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 259: CHINA: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 260: INDIA: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET
  • TABLE 261: INDIA: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 262: INDIA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 263: INDIA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 264: INDIA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 265: INDIA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 266: INDIA: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 267: INDIA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 268: INDIA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 269: INDIA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 270: INDIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 271: INDIA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 272: INDIA: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 273: ROAPAC: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 274: ROAPAC: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 275: ROAPAC: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 276: ROAPAC: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 277: ROAPAC: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 278: ROAPAC: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 279: ROAPAC: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 280: ROAPAC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 281: ROAPAC: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 282: ROAPAC: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 283: ROAPAC: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 284: ROAPAC: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 285: LATIN AMERICA: BIOSURGERY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 286: LATIN AMERICA: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 287: LATIN AMERICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 288: LATIN AMERICA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 289: LATIN AMERICA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 290: LATIN AMERICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 291: LATIN AMERICA: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 292: LATIN AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 293: LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 294: LATIN AMERICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 295: LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 296: LATIN AMERICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 297: LATIN AMERICA: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 298: BRAZIL: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET
  • TABLE 299: BRAZIL: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 300: BRAZIL: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 301: BRAZIL: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 302: BRAZIL: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 303: BRAZIL: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 304: BRAZIL: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 305: BRAZIL: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 306: BRAZIL: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 307: BRAZIL: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 308: BRAZIL: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 309: BRAZIL: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 310: BRAZIL: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 311: MEXICO: KEY MACROINDICATORS FOR THE BIOSURGERY MARKET
  • TABLE 312: MEXICO: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 313: MEXICO: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 314: MEXICO: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 315: MEXICO: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 316: MEXICO: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 317: MEXICO: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 318: MEXICO: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 319: MEXICO: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 320: MEXICO: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 321: MEXICO: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 322: MEXICO: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 323: MEXICO: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 324: ROLA: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 325: ROLA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 326: ROLA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 327: ROLA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 328: ROLA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 329: ROLA: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 330: ROLA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 331: ROLA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 332: ROLA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 333: ROLA: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 334: ROLA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 335: REST OF LATIN AMERICA: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 336: MIDDLE EAST AND AFRICA: BIOSURGERY MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 337: MIDDLE EAST AND AFRICA: SURGICAL SEALANTS & ADHESIVES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 338: MIDDLE EAST AND AFRICA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 339: MIDDLE EAST AND AFRICA: NATURAL/BIOLOGICAL SEALANTS MARKET, BY ORIGIN, 2016-2023 (USD MILLION)
  • TABLE 340: MIDDLE EAST AND AFRICA: SYNTHETIC & SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 341: MIDDLE EAST AND AFRICA: ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 342: MIDDLE EAST AND AFRICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 343: MIDDLE EAST AND AFRICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 344: MIDDLE EAST AND AFRICA: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 345: MIDDLE EAST AND AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 346: MIDDLE EAST AND AFRICA: BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 347: MIDDLE EAST AND AFRICA: BIOSURGERY MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 348: GROWTH STRATEGY MATRIX (2015-2018)
  • TABLE 349: PRODUCT LAUNCHES, 2015-2018
  • TABLE 350: AGREEMENTS AND PARTNERSHIPS, 2015-2018
  • TABLE 351: ACQUISITIONS, 2015-2018
  • TABLE 352: EXPANSIONS, 2015-2018

LIST OF FIGURES

  • FIGURE 1: BIOSURGERY MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: PRIMARY SOURCES
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: BIOSURGERY MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: NATURAL/BIOLOGICAL SEALANTS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: HEMOSTATS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: SOFT-TISSUE ATTACHMENTS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 12: ADHESION BARRIER MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 13: SYNTHETIC ADHESION BARRIER MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 14: BONE-GRAFT SUBSTITUTE MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 15: BIOSURGERY MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 16: BIOSURGERY MARKET SHARE, BY REGION
  • FIGURE 17: INCREASE IN THE VOLUME OF SURGERIES TO DRIVE MARKET GROWTH
  • FIGURE 18: BONE-GRAFT SUBSTITUTES HELD THE LARGEST SHARE OF THE APAC MARKET IN 2017
  • FIGURE 19: THE US ACCOUNTED FOR THE LARGEST SHARE OF THE BIOSURGERY MARKET IN 2017
  • FIGURE 20: APAC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 21: DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 22: GROWTH IN GERIATRIC POPULATION, BY REGION, 2015-2050
  • FIGURE 23: INCREASING MARKET CONSOLIDATION & RISING FOCUS ON PRODUCT DEVELOPMENTS ARE THE MAJOR TRENDS IN THE BIOSURGERY MARKET
  • FIGURE 24: PRODUCT LAUNCHES AND APPROVALS - KEY GROWTH STRATEGY ADOPTED BY MAJOR PLAYERS IN THE BIOSURGERY MARKET (2015-2018)
  • FIGURE 25: PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES
  • FIGURE 26: BIOSURGERY MARKET: VENDOR BENCHMARKING
  • FIGURE 27: BONE-GRAFT SUBSTITUTES SEGMENT TO DOMINATE THE BIOSURGERY MARKET IN 2018
  • FIGURE 28: DEMINERALIZED BONE MATRIX SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 29: SYNTHETIC MESHES SEGMENT TO GROW AT THE HIGHEST CAGR
  • FIGURE 30: COMBINATION HEMOSTATS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 31: SYNTHETIC AND SEMI-SYNTHETIC SEALANTS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 32: HUMAN BLOOD-BASED SEALANTS AND ADHESIVES TO DOMINATE THE NATURAL/BIOLOGICAL SEALANTS & ADHESIVES MARKET
  • FIGURE 33: SYNTHETIC ADHESION BARRIERS TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 34: ORTHOPEDIC SURGERY TO DOMINATE THE BIOSURGERY APPLICATIONS MARKET DURING THE FORECAST PERIOD
  • FIGURE 35: GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA PACIFIC ARE EMERGING HOTSPOTS
  • FIGURE 36: NORTH AMERICA: BIOSURGERY MARKET SNAPSHOT
  • FIGURE 37: EUROPE: BIOSURGERY MARKET SNAPSHOT
  • FIGURE 38: APAC: BIOSURGERY MARKET SNAPSHOT
  • FIGURE 39: KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2015 AND MARCH 2018
  • FIGURE 40: SURGICAL SEALANTS AND ADHESIVES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 41: HEMOSTATIC AGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 42: BONE-GRAFT SUBSTITUTES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 43: ADHESION BARRIERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 44: SOFT-TISSUE ATTACHMENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 45: BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 46: B.BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2017)
  • FIGURE 47: C.R. BARD: COMPANY SNAPSHOT (2016)
  • FIGURE 48: JOHNSON & JOHNSON: COMPANY SNAPSHOT (2017)
  • FIGURE 49: MEDTRONIC: COMPANY SNAPSHOT (2017)
  • FIGURE 50: GETINGE GROUP: COMPANY SNAPSHOT (2017)
  • FIGURE 51: INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 52: COMMONWEALTH SERUM LABORATORIES: COMPANY SNAPSHOT (2017)
  • FIGURE 53: SANOFI: COMPANY SNAPSHOT (2017)
  • FIGURE 54: PFIZER INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 55: STRYKER CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 56: CRYOLIFE: COMPANY SNAPSHOT (2017)

"The biosurgery market projected to grow at a CAGR of 6.5%."

The biosurgery market is projected to reach USD 15.58 billion by 2023 from estimated USD 11.36 billion in 2018 at a CAGR of 6.5%. Factors such as the growing geriatric population and corresponding chronic diseases, increasing volume of surgeries and prevalence of severe trauma injuries, and rising need for effective blood loss management in patients are expected to drive the growth of this market during the forecast period of 2018 to 2023. However, stringent regulatory framework and the requirement of skilled personnel for the effective use of biosurgery products may challenge market growth to a certain extent in the coming years.

"The surgical sealants and adhesives segment is projected to witness the highest growth during the forecast period."

On the basis of product, the biosurgery is broadly segmented into bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and staple-line reinforcement agents. The surgical sealants and adhesives segment is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to a large number of commercially available sealants and their higher utilization (as compared to other biosurgery products) by surgeons in various surgeries.

"Asia Pacific to witness the highest growth during the forecast period."

Asia Pacific is expected to witness the highest growth during the forecast period (2018 to 2023). The region's large geriatric population, large patient population, improving healthcare infrastructure, growing medical tourism, and epidemiological shift from infectious to chronic diseases are driving the growth of this market.

Break of primary participants from supply side was as mentioned below:

  • By Company Type - Tier 1-42%, Tier 2-35% and Tier 3-23%
  • By Designation - C Level-28%, Director Level-35%, Others-37%
  • By Region - North America-35%, Europe-25%, Asia Pacific-19%, Latin America- 11%, and the Middle East and Africa-10%

Some of the major market players in the biosurgery market are: Johnson & Johnson (US), Sanofi (France), Baxter (US), C.R. Bard (US), Integra LifeSciences (US), MAQUET (Sweden), Medtronic (Ireland), Cohera Medical (US), Hemostasis (US), Stryker (US), B.Braun (Germany), CSL (Australia), Pfizer (US), and CryoLife (US).

Research Coverage:

The report analyzes the biosurgery market and aims at estimating the market size and future growth potential of this market based on various segments such as product, application, and region. The report also includes a product portfolio matrix and product pipeline analysis of biosurgery products available in the market and are under one of the clinical trial phases respectively. The report also provides a competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them, garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global biosurgery market. The report analyzes this market by product, application, and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global biosurgery market
  • Market Development: Comprehensive information on the lucrative emerging markets by product, application, and region
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global biosurgery market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global biosurgery market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. BIOSURGERY MARKET: OVERVIEW
  • 4.2. APAC: BIOSURGERY MARKET, BY TYPE & COUNTRY (2017)
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE BIOSURGERY MARKET (2017)
  • 4.4. GEOGRAPHIC MIX: BIOSURGERY MARKET, 2016-2023(USD MILLION)
  • 4.5. BIOSUGERY MARKET: DEVELOPING VS. DEVELOPED MARKETS, 2018 VS. 2023(USD MILLION)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. DRIVERS
    • 5.2.1. RISING GERIATRIC POPULATION
    • 5.2.2. INCREASING VOLUME OF SURGERIES AND PREVALENCE OF SEVERE TRAUMA INJURIES
    • 5.2.3. STRONG FOCUS ON R&D LEADING TO THE LAUNCH OF NEW AND ADVANCED PRODUCTS
    • 5.2.4. RISING NEED FOR EFFECTIVE BLOOD LOSS MANAGEMENT IN PATIENTS
  • 5.3. MARKET RESTRAINTS
    • 5.3.1. HIGH PRICE OF BIOSURGERY PRODUCTS & RISING COST OF SURGICAL PROCEDURES
  • 5.4. MARKET OPPORTUNITIES
    • 5.4.1. UNTAPPED EMERGING MARKETS
  • 5.5. MARKET CHALLENGES
    • 5.5.1. STRINGENT REGULATORY FRAMEWORK
    • 5.5.2. REQUIREMENT OF SKILLED PERSONNEL FOR THE EFFECTIVE USE OF BIOSURGERY PRODUCTS

6. INDUSTRY INSIGHTS

  • 6.1. INDUSTRY TRENDS
    • 6.1.1. INCREASING MARKET CONSOLIDATION
    • 6.1.2. RISING FOCUS ON PRODUCT DEVELOPMENTS & LAUNCHES
    • 6.1.3. GROWING DEMAND FOR DENTAL BONE-GRAFT SUBSTITUTES
    • 6.1.4. GROWING PREFERENCE FOR GELATIN-BASED ADHESIVES & HYDROGELS IN SURGICAL PROCEDURES
  • 6.2. REGULATORY ANALYSIS
    • 6.2.1. NORTH AMERICA
      • 6.2.1.1. US
      • 6.2.1.2. Canada
    • 6.2.2. EUROPE
    • 6.2.3. APAC
      • 6.2.3.1. Japan
      • 6.2.3.2. China
      • 6.2.3.3. India
  • 6.3. STRATEGIC BENCHMARKING
    • 6.3.1. BIOSURGERY MARKET: PRODUCT PORTFOLIO ANALYSIS
    • 6.3.2. NATURAL/BIOLOGICAL SEALANTS & ADHESIVES: PRODUCT PORTFOLIO ANALYSIS
    • 6.3.3. SYNTHETIC & SEMISYNTHETIC SEALANTS & ADHESIVES: PRODUCT PORTFOLIO ANALYSIS
    • 6.3.4. HEMOSTATIC AGENTS: PRODUCT PORTFOLIO ANALYSIS
    • 6.3.5. ADHESION BARRIERS: PRODUCT PORTFOLIO ANALYSIS
    • 6.3.6. SOFT-TISSUE ATTACHMENTS: PRODUCT PORTFOLIO ANALYSIS
    • 6.3.7. BONE-GRAFT SUBSTITUTES : PRODUCT PORTFOLIO ANALYSIS

7. BIOSURGERY MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. BONE-GRAFT SUBSTITUTES
    • 7.2.1. DEMINERALIZED BONE MATRIX
    • 7.2.2. SYNTHETIC BONE GRAFTS
    • 7.2.3. BONE MORPHOGENETIC PROTEINS
    • 7.2.4. OTHER BONE-GRAFT SUBSTITUTES
  • 7.3. SOFT-TISSUE ATTACHMENTS
    • 7.3.1. SYNTHETIC MESHES
    • 7.3.2. BIOLOGICAL MESHES
      • 7.3.2.1. Allografts
      • 7.3.2.2. Xenografts
  • 7.4. HEMOSTATIC AGENTS
    • 7.4.1. THROMBIN-BASED HEMOSTATIC AGENTS
    • 7.4.2. OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATIC AGENTS
    • 7.4.3. COMBINATION HEMOSTATIC AGENTS
  • 7.5. SURGICAL SEALANTS AND ADHESIVES
    • 7.5.1. NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES
      • 7.5.1.1. Natural/Biological sealants and adhesives, by type
        • 7.5.1.1.1. Fibrin sealants
        • 7.5.1.1.2. Collagen-based sealants
        • 7.5.1.1.3. Gelatin-based sealants
        • 7.5.1.1.4. Albumin-based sealants
        • 7.5.1.1.5. Other natural/biological sealants
      • 7.5.1.2. Natural/Biological sealants and adhesives, by origin
        • 7.5.1.2.1. Human blood-based sealants and adhesives
        • 7.5.1.2.2. Animal-based sealants and adhesives
    • 7.5.2. SYNTHETIC AND SEMI-SYNTHETIC SEALANTS AND ADHESIVES
      • 7.5.2.1. Peg hydrogels
      • 7.5.2.2. Cyanoacrylate-based sealants and adhesives
      • 7.5.2.3. Urethane-based sealants and adhesives
      • 7.5.2.4. Other synthetic and semi-synthetic sealants and adhesives
  • 7.6. ADHESION BARRIERS
    • 7.6.1. SYNTHETIC ADHESION BARRIERS
      • 7.6.1.1. Hyaluronic acid-based adhesion barriers
      • 7.6.1.2. Regenerated cellulose-based adhesion barriers
      • 7.6.1.3. Peg-based adhesion barriers
      • 7.6.1.4. Ther synthetic adhesion barriers
    • 7.6.2. NATURAL ADHESION BARRIERS
      • 7.6.2.1. Collagen & protein adhesion barriers
      • 7.6.2.2. Fibrin-based adhesion barriers
  • 7.7. STAPLE-LINE REINFORCEMENT AGENTS

8. BIOSURGERY MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. ORTHOPEDIC SURGERY
  • 8.3. GENERAL SURGERY
  • 8.4. NEUROLOGICAL SURGERY
  • 8.5. CARDIOVASCULAR SURGERY
  • 8.6. RECONSTRUCTIVE SURGERY
  • 8.7. GYNECOLOGICAL SURGERY
  • 8.8. UROLOGICAL SURGERY
  • 8.9. THORACIC SURGERY

9. BIOSURGERY MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. UK
    • 9.3.3. FRANCE
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. REST OF EUROPE (ROE)
  • 9.4. ASIA PACIFIC
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA PACIFIC
  • 9.5. LATIN AMERICA
    • 9.5.1. BRAZIL
    • 9.5.2. MEXICO
    • 9.5.3. REST OF LATIN AMERICA
  • 9.6. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
    • 10.2.1. SURGICAL SEALANTS AND ADHESIVES
    • 10.2.2. HEMOSTATIC AGENTS
    • 10.2.3. BONE-GRAFT SUBSTITUTES
    • 10.2.4. ADHESION BARRIERS
    • 10.2.5. SOFT-TISSUE ATTACHMENTS
  • 10.3. COMPETITIVE SITUATIONS AND TRENDS
    • 10.3.1. PRODUCT LAUNCHES AND APPROVALS
    • 10.3.2. AGREEMENTS AND PARTNERSHIPS
    • 10.3.3. ACQUISITIONS
    • 10.3.4. EXPANSIONS

11. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, SWOT Analysis, Mnm View)*

  • 11.1. BAXTER INTERNATIONAL, INC.
  • 11.2. B.BRAUN MELSUNGEN AG
  • 11.3. C.R. BARD
  • 11.4. JOHNSON & JOHNSON
  • 11.5. MEDTRONIC, PLC.
  • 11.6. MAQUET HOLDING B.V. & CO. KG. (GETINGE GROUP)
  • 11.7. COHERA MEDICAL INC.
  • 11.8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • 11.9. COMMONWEALTH SERUM LABORATORIES (CSL)
  • 11.10. HEMOSTASIS, LLC
  • 11.11. SANOFI
  • 11.12. PFIZER INC.
  • 11.13. STRYKER CORPORATION
  • 11.14. CRYOLIFE, INC.

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, Mnm View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORT
  • 12.7. AUTHOR DETAILS
Back to Top
전화 문의
F A Q